XML 21 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements Of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
OPERATING ACTIVITIES      
Net income $ 21,781,000 $ 28,691,000 $ 14,202,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Impairment (reversals) / charges (365,000) 3,101,000 2,877,000
Gain on extinguishment of debt obligations   (1,423,000) (10,452,000)
Gain on sales   (14,376,000) (609,000)
Straight-line rents (506,000) (761,000) (1,481,000)
Provision for doubtful accounts 1,463,000 1,985,000 1,572,000
Depreciation and amortization 38,594,000 38,700,000 45,663,000
Amortization of intangible lease liabilities (3,125,000) (4,322,000) (4,446,000)
Expense relating to share-based compensation, net 3,168,000 3,531,000 3,701,000
Amortization (including accelerated write-off) of deferred financing costs 1,611,000 2,158,000 2,162,000
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:      
Rents and other receivables, net (1,346,000) (2,989,000) (1,606,000)
Prepaid expenses and other (1,929,000) (2,460,000) (2,696,000)
Accounts payable and accrued liabilities (210,000) (950,000) 607,000
Net cash provided by operating activities 59,136,000 50,885,000 49,494,000
INVESTING ACTIVITIES      
Acquisitions of real estate (42,991,000) (38,861,000) (32,818,000)
Expenditures for real estate improvements (12,698,000) (16,254,000) (20,288,000)
Net proceeds from sales of real estate 5,891,000 102,124,000 34,713,000
Repayment of note receivable     1,100,000
Construction escrows and other 1,922,000 2,107,000 2,221,000
Net cash (used in) provided by investing activities (47,876,000) 49,116,000 (15,072,000)
FINANCING ACTIVITIES      
Repayments under revolving credit facility (186,400,000) (231,500,000) (105,000,000)
Advances under revolving credit facility 192,400,000 150,000,000 177,500,000
Advances under term loans 100,000,000 150,000,000 50,000,000
Repayment under term loan     (75,000,000)
Mortgage repayments (114,828,000) (177,094,000) (77,069,000)
Payments of debt financing costs (2,879,000) (1,312,000) (1,893,000)
Noncontrolling interests:      
Purchase of joint venture minority interests share   (960,000) (665,000)
Distributions to consolidated joint venture minority interests (11,216,000)   (1,552,000)
Distributions to limited partners (78,000) (86,000) (52,000)
Redemptions of OP Units (7,000) (437,000) (170,000)
Common stock sales less issuance expenses, net 41,741,000 41,163,000 (64,000)
Net proceeds from sales of preferred stock     59,849,000
Redemption of preferred stock     (34,992,000)
Preferred stock dividends (14,408,000) (14,408,000) (14,429,000)
Distributions to common shareholders (17,001,000) (15,841,000) (14,434,000)
Net cash (used in) financing activities (12,676,000) (100,475,000) (37,971,000)
Net (decrease) in cash and cash equivalents (1,416,000) (474,000) (3,549,000)
Cash and cash equivalents at beginning of period 3,499,000 3,973,000 7,522,000
Cash and cash equivalents at end of period $ 2,083,000 $ 3,499,000 $ 3,973,000